Results 161 to 170 of about 8,472 (213)

Efficacy and safety of transjugular intrahepatic portosystemic shunt in hepatic sinusoidal obstruction syndrome: systematic review and meta-analysis. [PDF]

Front Med (Lausanne)
Jiang X, Ma X, Tian S, Peng L.
europepmc   +1 more source

Use of Partial Splenic Embolization Following a Transjugular Intrahepatic Portosystemic Shunt to Reduce Persistent Portal Hypertension Sequelae. [PDF]

Cureus
Schultz G, Naas M, Webb J.
europepmc   +1 more source

Sarcopenia as a Risk Factor in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt (TIPS) Implantation. [PDF]

Diagnostics (Basel)
Büttner L, Aigner A, Stegherr R, Iseke S, Jonczyk M, Lüdemann WM, Auer TA, Collettini F, Schnapauff D, de Bucourt M, Gebauer B, Geisel D, Böning G.   +12 more
europepmc   +1 more source

Cross-sight transjugular intrahepatic portosystemic shunt (CS-TIPS): combined ultrasound-fluoroscopy guidance for simultaneous percutaneous portal and hepatic vein puncture and access closure with plug deployment. [PDF]

Radiol Med
Riga MG, Triggiani S, Mortellaro S, Angileri SA, Ierardi AM, Mortellaro SR, Carrafiello G.   +6 more
europepmc   +1 more source

The transjugular intrahepatic portosystemic shunt (TIPS)

Clinical Radiology, 2009
The creation of an intrahepatic portosystemic shunt via a transjugular approach (TIPS) is an interventional radiological procedure used to treat the complications of portal hypertension. TIPS insertion is principally indicated to prevent or arrest variceal bleeding when medical or endoscopic treatments fail, and in the management refractory ascites ...
A R, Owen, A J, Stanley, A, Vijayananthan, J G, Moss   +3 more
openaire   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

The Transjugular Intrahepatic Portosystemic Shunt: An Update

American Journal of Roentgenology, 2012
The purpose of this article is to review the indications, outcomes, complications, patient selection, and technical aspects of creating a transjugular intrahepatic portosystemic shunt (TIPS).The best available evidence supports the use of TIPS in secondary prevention of variceal bleeding and in refractory ascites, although TIPS is also commonly used ...
Nicholas Fidelman, Sharon W Kwan, Roy L Gordon   +2 more
exaly   +3 more sources

Transjugular intrahepatic portosystemic shunt and alfapump® system for refractory ascites in liver cirrhosis: Outcomes and complications

United European Gastroenterology Journal, 2020
BACKGROUND Treatment of refractory ascites in liver cirrhosis is challenging. Transjugular intrahepatic portosystemic shunt and alfapump® have been proposed for the management, but few data comparing both exist. AIMS The aim of this study was to
Valerie Will, Susana G Rodrigues, Guido Stirnimann   +2 more
exaly   +2 more sources

Transjugular Intrahepatic Portosystemic Shunt

Contemporary Diagnostic Radiology, 2022
Chronic liver disease is the 11th leading cause of mortality in the United States.1 Portal hypertension is a common endpoint for progressive liver disease, and can clinically manifest as refractory ascites, splenomegaly, and life-threatening esophageal and gastric variceal bleeding.
Michelle T. Martin, Wadih Chacra
  +4 more sources

Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt

Clinics in Liver Disease, 2012
Transjugular intrahepatic portosystemic shunt (TIPS) has been used for more than 20 years to treat some of the complications of portal hypertension. When TIPS was initially proposed, it was claimed that the optimal calibration of the shunt could allow an
Oliviero Riggio, Silvia Nardelli, Federica Moscucci   +2 more
exaly   +2 more sources

Direct intrahepatic portocaval shunt (DIPS) or transjugular transcaval intrahepatic portosystemic shunt (TTIPS) to treat complications of portal hypertension: Indications, technique, and outcomes beyond Budd-Chiari syndrome

Clinics and Research in Hepatology and Gastroenterology, 2022
Transjugular intrahepatic portosystemic shunt (TIPS) is nowadays the benchmark treatment of severe portal hypertension complications. However, besides usual contraindication to the procedure (namely recurrent hepatic encephalopathy, severe liver ...
Florent Artru, Eleni Moschouri, Alban Denys   +2 more
exaly   +2 more sources